Business research

New release from The Business Research Company Highlights

implantable infusion pump market

The global implantable infusion pump market size is expected to grow from USD 17.42 billion in 2021 to USD 18.26 billion in 2022 at a compound annual growth rate (CAGR) of 4.8%. The global implantable infusion pump market is expected to reach USD 21.79 billion in 2026 with a CAGR of 4.5%.

The trade research company offers the report of the global Implantable Infusion Pumps market 2022 in its research report store. This is the most comprehensive report available on this market and will help you gain a truly global perspective as it covers 60 geographies. The regional and country breakdowns section gives an analysis of the market in each geography and the market size by region and country. It also compares historical and forecast market growth and highlights important trends and strategies that market players may adopt.

Request a free sample of this research study:

The implantable infusion pump market includes sales of implantable infusion pumps and related services by entities (organizations, individual traders and partnerships) that manufacture implantable infusion pumps. implantable infusion pumps are used to extract samples of cells or tissue from the patient’s body to be examined to determine the presence of disease.

Some key players in the implantable infusion pump market are Becton Dickinson and Company (BD), Cook Medical, Argon Medical Devices, Hologic, Boston Scientific Corporation, Cardinal Health, B. Braun Melsungen AG.

The countries covered in the global implantable infusion pump market are Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Colombia, Czech Republic, Denmark, Egypt, Finland, France, Germany, Hong Kong, India, Indonesia, Ireland. , Israel, Italy, Japan, Malaysia, Mexico, Netherlands, New Zealand, Nigeria, Norway, Peru, Philippines, Poland, Portugal, Romania, Russia, Saudi Arabia, Singapore, South Africa, South Korea, Spain, Sweden, Switzerland, Thailand, Turkey, United Arab Emirates, United Kingdom, United States, Venezuela, Vietnam.

Regions covered in the global implantable infusion pumps market are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and South America. ‘Africa.

Implantable Infusion Pump Market Segmentation:
By type
1. Patient Controlled Analgesia (PCA) Pumps
2. Enteral pumps
3. Insulin pumps
4. Elastomeric pumps
5. Syringe pumps
6. Others

By request
1. Oncology
2. Pediatrics/Neonatology
3. Gastroenterology
4. Hematology
5. Diabetes

Per end user
1. Hospitals
2. Outpatient surgery centers
3. Specialty clinics

Read more about the report at –

The table of contents of the report includes
1. Summary
2. Characteristics of the Implantable Infusion Pump Market
3. Implantable Infusion Pump Market Trends and Strategies
4. Impact of Covid-19 on implantable infusion pumps
5. Implantable Infusion Pump Market Size and Growth
28. Major Mergers and Acquisitions in the Implantable Infusion Pump Market
29. Implantable Infusion Pump Market Future Prospects and Potential Analysis
30. Annex

This report covers market trends and dynamics of the Implantable Infusion Pumps market in major countries – Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK and USA. United. The report also includes consumer surveys and various future opportunities for the market.

Buy the report directly here:

Contact information:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: [email protected]
Check out our blog:

And follow us on:

About Us:
The Business Research Company ( is a business information company that excels in business, market and consumer research. She has published over 3,000 industry reports, covering over 2,500 market segments and 60 geographies. The reports are based on 150,000 datasets, extensive secondary research and proprietary insights from interviews with industry leaders. Reports are updated with detailed analysis of the impact of COVID-19 on various markets.

This press release was published on openPR.